Ataxia-Telangiectasia (AT) is an incurable childhood disorder characterized by accelerated aging and progressive cerebellum degeneration causing several disabilities. Despite the discovery of causative mutations in the gene ATM (AT-mutated), its unknown pathogenic mechanism makes developing a treatment extremely difficult. It is known that ATM senses DNA double strand breaks (DSBs) and triggers downstream repair pathways including cell-cycle arrest and apoptosis. The lack of proper DSB repair due to the inherited ATM mutation in AT is thought to lead to the accumulation of unrepaired DSBs and increase genomic instability such as genomic rearrangement and aneuploidy. However, it is unclear how abnormal DSB repair relates to genomic instability and how the genomic instability impacts pathogenicity. Recent studies have reported frequent retrotransposition of transposable elements (TEs) in engineered ATM-deficient cells, increased DNA copies of TEs in AT patient brains, and abnormal expression of satellite repeats in DSB repair defective cells. Along with our published and unpublished data, these suggest a hypothesis that repeat aberrations may be a frequent form of genomic instability and pathogenic in AT. Our published single-neuron analysis showed that somatic retrotransposition occurred in neuronal progenitors and it created low-level somatic mosaicism in normal human brain. This suggests hypotheses that 1) neurons in AT patients may have a mixed population of somatic mutations occurring at different time points during development, and 2) late mutations present in a limited number of neurons may be critical determinants of cell death. Because those rare mutations cannot be detected with typical pooled-cell analysis, we propose to analyze genomes of individual neurons. However, the single-cell genomic approaches need to address significant technical challenges introduced by the whole genome amplification process necessary in current single-cell sequencing techniques. Thus, with a development of novel computational methods, we will characterize somatic mutations leading to multiple forms of genomic instability, including repeat aberration, in AT and assess their functional impact to neurodegeneration.

Public Health Relevance

Ataxia-Telangiectasia (AT) is a neurodegenerative childhood disorder that is currently incurable and characterized by accelerated aging and cerebellum degeneration leading to motility loss. The aim of this proposal is to characterize genomic instability in AT by single-cell genomic analysis and to assess their impact on neuronal cell death. This project will not only enable discovery of biological mechanisms in AT pathogenesis but also provide a computational framework for single-cell analysis that can be applied to other neurodevelopmental and neurodegenerative diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
7K01AG051791-02
Application #
9461304
Study Section
Neuroscience of Aging Review Committee (NIA)
Program Officer
Wise, Bradley C
Project Start
2017-05-01
Project End
2021-04-30
Budget Start
2017-05-01
Budget End
2018-04-30
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Boston Children's Hospital
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Jung, Hyunchul; Choi, Jung Kyoon; Lee, Eunjung Alice (2018) Immune signatures correlate with L1 retrotransposition in gastrointestinal cancers. Genome Res 28:1136-1146
Lee, Sejoon; Lee, Soohyun; Ouellette, Scott et al. (2017) NGSCheckMate: software for validating sample identity in next-generation sequencing studies within and across data types. Nucleic Acids Res 45:e103
McConnell, Michael J; Moran, John V; Abyzov, Alexej et al. (2017) Intersection of diverse neuronal genomes and neuropsychiatric disease: The Brain Somatic Mosaicism Network. Science 356:
Jung, Hyunchul; Lee, Donghoon; Lee, Jongkeun et al. (2015) Intron retention is a widespread mechanism of tumor-suppressor inactivation. Nat Genet 47:1242-8